Feedback / Questions
liposomal Bcl2 (BP1002) - Bio-Path
https://www.bloomberg.com/press-releases/2021-08-24/bio-path-holdings-announces-clearance-of-investigational-new-drug-application-for-bp1002-in-refractory-relapsed-acute-myeloid
Aug 24, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next